So we and they’re all the leading indicators, if you will, make us feel like we’re heading in the right direction when Amy was saying spillover, so we see little insights and clues that would say we’re not done yet. But to your question you asked, I mean, clearly, as Amy mentioned, new writers are great, existing writers are writing more is even better. So, we focus on getting our existing writer base to write more. So roughly, we have ample number of physicians to grow this brand to a big level. We just got to get them to write more. And we think some of that resistance is related to the frustration with the Affordable Care Act. In general, brands frustrate them in this category. So, Amy built a network of specialty pharm that help, but that that guidance will help more.
But in the meantime, we’re excited with the growth we’re seeing. In retail, based on some of the analytics team is doing, it’s more common.
Naz Rahman: Okay. That was helpful. Thanks for taking my questions and congratulations on the progress.
Alfred Altomari: Yes. We appreciate it.
Operator: Thank you. And this concludes the question-and-answer period. I will turn it back to Al Altomari for final remarks.
Alfred Altomari: Well, thanks, everybody. This will be kind of a bit reflective of the year. When we first talk to you about our ambitious goals of putting up as much as $25 million plus this year, and we showed you the first order, which was $3.8 million. Look, truth be known, a number you called me and said, how are you going to get there? How are you going to get there? And then concurrently, we said we’re heading to profitability. That appeared to be a steep mountain we were having to climb, but this management team believed in this brand and the indicators we were seeing. So, that led to us posting $5.5 million in the second quarter now $6.7 million. And, we’re still saying we think we can get to $25 million. So you could do the math.
We expect to see big growth in the fourth quarter and that should expect us moving forward into the first quarter. We continue to see growth. So, we’re just excited to be here at this moment. And then looking forward, kind of the happy thought, when we look at the business and saying, okay, we could be a company throwing off cash next year, and we expect it to be, but we called that no our the days of, having an interesting decision to make as a company is what do we do with that cash? Do we let it accrue? But I believe we have four opportunities to grow this business even more. And this is the debate we’re beginning to have on the eve of this, hopefully, happy thought. Number one, our partners work. So, should we invest more in our partnerships?
Number two, our salesforce works and works well. Should we do more with the salesforce? Amy, early on showed you a digital works. What should we do there? And but strategically, we also say we need to have more of a broader offering. We need to have one-on-one product. So, this is the debate we’d love to have with ourselves and eventually bring in. But for right now, we’re not done. Our short-term goals we’ve got to post $25 million, and then we’ve got to show you that we can get this business to throw off cash, but we have a high degree of confidence. And then Oren’s question to me and Naz, as of my confidence that the days for this business look better ahead, but with the environment with the ACA, that just is gravy, but you have our commitment, we’ll get there, without the help of DC.
Now with that said, we’d love Secretary Pacira in DC to help us and help this category let women get contraception and that their physicians want them to have. So, thank you for your support. Thank you for your challenges of the team of saying, can we get there? We’re almost there and then we’ll rest up and do it again in ‘24, but thank you for support. Thank you for your tough questions. And, you made us a better management team, but thank you.
Operator: And thank you all for joining our call, and you may now disconnect.
